Skip to Content

Inoviq Ltd BDLSF

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BDLSF is trading at a 739% premium.
Price
$0.12
Fair Value
$2.72
Uncertainty
Extreme
1-Star Price
$7.15
5-Star Price
$1.24
Economic Moat
Vxdnm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BDLSF is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
183,586 / 183,586

Key Statistics

Price/Earnings (Normalized)
Price/Sales
2.07
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Inoviq Ltd is engaged in developing and commercializing a portfolio of diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases. The company has commercialized the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate, and other cancers.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Core
Total Number of Employees
85

Comparables

Valuation

Metric
BDLSF
TIHE
300642
Price/Earnings (Normalized)
40.78
Price/Book Value
0.021.31
Price/Sales
2.073.86
Price/Cash Flow
12.59
Price/Earnings
BDLSF
TIHE
300642

Financial Strength

Metric
BDLSF
TIHE
300642
Quick Ratio
4.935.66
Current Ratio
4.947.12
Interest Coverage
105.34
Quick Ratio
BDLSF
TIHE
300642

Profitability

Metric
BDLSF
TIHE
300642
Return on Assets (Normalized)
2.93%
Return on Equity (Normalized)
3.23%
Return on Invested Capital (Normalized)
2.83%
Return on Assets
BDLSF
TIHE
300642
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
PvrkmxhtmQzwb$218.4 Bil
Danaher Corp
DHR
DfsfhyhcwLjnhh$188.8 Bil
IDEXX Laboratories Inc
IDXX
CnjlrqpwrfVlxfkm$41.6 Bil
IQVIA Holdings Inc
IQV
QcxldtcfgVxnlx$38.8 Bil
Agilent Technologies Inc
A
MsgfvqlksBhrky$37.9 Bil
Mettler-Toledo International Inc
MTD
ZrdpbhjrNjrhf$31.1 Bil
Icon PLC
ICLR
LcsjhblkDdgvdv$25.9 Bil
Waters Corp
WAT
RzcdtgydgBww$17.5 Bil
Illumina Inc
ILMN
QhvndgpLcjchc$17.3 Bil
Labcorp Holdings Inc
LH
YzfjkfwwjmPdjrcbk$16.8 Bil

Sponsor Center